Suven Pharmaceuticals Limited Share Price

Equities

SUVENPHAR

INE03QK01018

Pharmaceuticals

End-of-day quote NSE India S.E. 03:30:00 19/07/2024 am IST 5-day change 1st Jan Change
820.6 INR -5.93% Intraday chart for Suven Pharmaceuticals Limited -3.24% +13.53%
Sales 2024 10.51B 126M Sales 2025 * 11.53B 138M Capitalization 209B 2.5B
Net income 2024 3B 35.88M Net income 2025 * 3.4B 40.67M EV / Sales 2024 16.4 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 18.1 x
P/E ratio 2024
57.4 x
P/E ratio 2025 *
61.2 x
Employees 1,193
Yield 2024 *
0.21%
Yield 2025 *
0.18%
Free-Float 89.97%
More Fundamentals * Estimated data
Dynamic Chart
1 day-5.93%
1 week-3.24%
Current month+2.06%
1 month+11.74%
3 months+27.31%
6 months+19.47%
Current year+13.53%
More quotes
1 week
815.10
Extreme 815.1
881.60
1 month
696.05
Extreme 696.05
889.70
Current year
585.20
Extreme 585.2
889.70
1 year
478.60
Extreme 478.6
889.70
3 years
390.50
Extreme 390.5
889.70
5 years
87.60
Extreme 87.6
889.70
10 years
87.60
Extreme 87.6
889.70
More quotes
Managers TitleAgeSince
Chief Executive Officer - 29/23/29
Director of Finance/CFO 30 01/01
Director/Board Member - 29/23/29
Members of the board TitleAgeSince
Director/Board Member 67 29/23/29
Director/Board Member 48 09/11
Director/Board Member 62 09/11
More insiders
Date Price Change Volume
19/24/19 820.6 -5.93% 295,063
18/24/18 872.3 +1.60% 538,651
16/24/16 858.6 +2.07% 269,789
15/24/15 841.2 -0.82% 206,371
12/24/12 848.1 -0.70% 287,326

End-of-day quote NSE India S.E., July 19, 2024

More quotes
Suven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe, and others. In India, the Company sells bulk drugs and intermediates, chemicals, and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
820.6 INR
Average target price
670.5 INR
Spread / Average Target
-18.29%
Consensus
  1. Stock Market
  2. Equities
  3. SUVENPHAR Stock